Patients with this novel POT1 missense variant were diagnosed either with PTC (including mPTC), Hürthle (oncocytic) cell carcinoma (HCC), or benign thyroid nodules, however sometimes combining PTC and HCC, or coexisting with MNG (14, 16). This evidence concerns the gene POT1 and hepatocellular carcinoma.